Fundz

Dr. Atul R. Mahableshwarkar M.D. Joins Cybin Inc. as Senior Vice President, Clinical Development

PUBLIC · HELPJun 11, 2024

Position

Vice President

Company

Helus Pharma

Atul R. Mahableshwarkar
atul@cybin.com
TorontoOtherManufacturingBiotechnologyHealth CarePharmaceutical

Description

DAtul R. Mahableshwarkar has joined Cybin Inc. as Senior Vice President, Clinical Development

Quick answer

Dr. Atul R. Mahableshwarkar M.D. Joins Cybin Inc. as Senior Vice President, Clinical Development (June 11, 2024). Helus Pharma is based in Toronto, Ontario, Canada.

Who is the new Vice President at Helus Pharma?
Helus Pharma named Atul R. Mahableshwarkar Vice President, announced June 11, 2024.
What did Helus Pharma announce on June 11, 2024?
DAtul R. Mahableshwarkar has joined Cybin Inc. as Senior Vice President, Clinical Development
What does Helus Pharma do?
Helus Pharma is a mental health-focused biopharmaceutical company developing small-molecule Novel Serotonergic Agonists (NSAs) to improve treatment options.
Where is Helus Pharma based?
Helus Pharma is based in Toronto, Ontario, Canada.
Which similar companies made leadership changes around the same time?
Eli Lilly and Company (June 4, 2024), Contineum Therapeutics (June 3, 2024), AbbVie Inc. (June 20, 2024) and Assertio Holdings (May 29, 2024) also announced leadership changes within 45 days of Helus Pharma.

Source: Fundz verified event record.

Other recent leadership changes in Pharmaceutical and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Helus Pharma, and when

A new leader at Helus Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Helus Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Helus Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Helus Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Helus Pharma

Location

Toronto, Ontario, Canada

About

Helus Pharma is a mental health-focused biopharmaceutical company developing small-molecule Novel Serotonergic Agonists (NSAs) to improve treatment options. The company is advancing patient-centered innovation through clinical excellence to deliver meaningful and durable outcomes that support long-term healing.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Helus Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Greg
Senior decision-maker at this company
••••••••@••••••••

See Greg's verified email →

Atul
Likely contact at this company
••••••••@••••••••

See Atul's verified email →

Eric
Likely contact at this company
••••••••@••••••••

See Eric's verified email →

Aaron
Senior decision-maker at this company
••••••••@••••••••

See Aaron's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Helus Pharma's next move

Learn about Strategic plan

Helus Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.